A PYMNTS Company

China

Roger Zhang on Recent Regulatory Developments
 |  Apr 11, 2024

 In an interview conducted by Dr. Yujie Qian, a Senior Economist with Compass Lexecon, Dr. Roger Zhang, Vice President for Public Affairs at Tencent, discussed the recent regulatory developments…

Chinese Standard Essential Patents Licensing Negotiations and Dispute Resolution in Practice
 |  Apr 1, 2024

By Dragon Wang, Bing Wu, Yannan Li & Xiaolin Wang1   The Supreme People’s Court (“SPC”) recently handed down a second-instance judgment in the case of Advanced Codec Technologies, LLC…

Dr. John Yong Ren on the Broadcom/VMware Deal
 |  Jan 15, 2024

   Dr. John Yong Ren, founder and managing partner of T&D Associates, recently discussed the Broadcom/VMware deal in an interview with Dr. Sophie Yang, a Senior Vice President at…

Hub-and-Spoke Agreements: What to Expect in China After AML Amendments
 |  Dec 11, 2023

By Yingling WEI, Mingfang GONG, Zhe DONG, Sisi WANG1   I. Introduction “Hub-and-spoke agreements” are generally used to describe a triangular scheme where competing undertakings (“spokes”) reach horizontal monopoly agreements…

Legal Practices and Development Direction for Anti-Monopoly Supervision of Data in China
 |  Dec 4, 2023

By Bing Chen & Yongji Liu1   I. The Current Status of Data-related Monopoly Supervision in China Data has become one of the most important factors of production in the…

Self-Preferencing in China – New Antitrust Rules or Case-by-Case Enforcement?
 |  Aug 29, 2023

Self-preferencing has been a hot topic in the global antitrust community over the past few years – including in China. This paper looks at how China has attempted to address…

Market Shares as An Important Factor in China’s Resale Price Maintenance Enforcement
 |  Aug 16, 2023

By Peter J. Wang, Qiang Xue, Yizhe Zhang & David Wu1   I. Overview Resale price maintenance (“RPM”) has been a hotly discussed issue in China’s antitrust sphere over the…

Antitrust Chronicle® – Year of the Rabbit: Antitrust in China
 |  Mar 29, 2023

Dear Readers, We are delighted to release our CPI Antitrust Chronicle for March 2023, Year of the Rabbit: Antitrust in China. This collection of eight excellent articles is contributed by…

CPI Talks Q&A with Qing Li
 |  Mar 29, 2023

In this edition of CPI Talks we have the pleasure of speaking with Qing Li, Vice President of the China Society of Economic Reform and former Deputy Director General at…

Highlights and Issues Concerning the Amendment of China’s Antimonopoly Law
 |  Mar 29, 2023

The first amendment to the Anti-Monopoly Law of the PRC came into effect in August 2022 since it was promulgated in 2007. From a macro perspective, this amendment emphasizes the…

In Praise of SAMR’s Behavioral Remedies: Preventing Over-Deterrence in Global Merger Control
 |  Mar 29, 2023

This article examines the use of behavioral remedies in merger control in China, and contrasts it with the stance opposing conduct remedies in the U.S., UK, and other jurisdictions including…

Merger Remedies in China in 2022 and the Prevalence of “Continue to Supply Under Frand Principles” as the Remedies
 |  Mar 29, 2023

This Article examines the remedy imposed on the conditional approvals in China’s merger review in 2022. The five cases of conditional approvals in 2022 are summarised from both procedural and…

Loading...